Heterocyclic derivatives for modulation of calcium channels

Details Heterocyclic derivatives for modulation of calcium channels Heterocyclic derivatives for modulation of calcium channels

2005-06-22

2009-08-04

Anderson, Rebecca L (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S217030, C514S233200, C514S254110, C514S256000, C514S278000, C514S314000, C514S316000, C514S320000, C544S297000, C544S153000, C544S141000, C544S364000, C546S016000, C546S187000, C546S193000, C546S196000, C540S596000, C549S414000, C549S467000

Reexamination Certificate

active

07569604

ABSTRACT:
Heterocyclic derivatives act as Ca channel antagonists. The compositions are useful for treating or relieving Ca channel mediated conditions.

REFERENCES:
patent: 7265152 (2007-09-01), Saha et al.
patent: WO 02/098852 (2002-12-01), None
patent: WO 00/30683 (2003-10-01), None
patent: WO 2004041202 (2004-05-01), None
Database WPI Section ch, Week 200039 Derwent Publications Ltd., London, GB; AN 2000-451668, XP002350808 & WO 00/30683 A1 (Shionogi & CO LTD) Jun. 2, 2000 abstract pp. 51, 52; compounds I-24, I-32, I-33, I-62.

Affiliated with

Also associated with

Rating

Heterocyclic derivatives for modulation of calcium channels does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Heterocyclic derivatives for modulation of calcium channels, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclic derivatives for modulation of calcium channels will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4075900